Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer
Clinical trial NCT04385641 · UNKNOWN
Trial details
- NCT number
- NCT04385641
- Sponsor
- Shandong Golden Brick Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2021-10-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.